Prognostic value of SOX2 expression in neuroblastoma

Genes Chromosomes and Cancer

Volumn 50, Issue 5, 2011, Pages 374-377

  Gómez Mateo, María del Carmen ^a,b   Piqueras, Marta ^a,b   Påhlman, Sven ^c   Noguera, Rosa ^a   Navarro, Samuel ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL INFANTIL LA FE   (Spain)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SOX2;

ALK GENE; CANCER GROWTH; CANCER PATIENT; CANCER STEM CELL; CHROMOSOME 3Q; EMBRYONIC STEM CELL; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LETTER; MYCN GENE; NEUROBLASTOMA; ONCOGENE; OVERALL SURVIVAL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGNOSIS; SOX2 GENE;

HUMANS; INFANT; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROGNOSIS; SOXB1 TRANSCRIPTION FACTORS;

EID: 79952381009     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20859     Document Type: Letter

References (20)

1. Boer B, Kopp J, Mallanna S, Desler M, Chakravarthy H, Wilder PJ, Bernadt C, Rizzino A. 2007. Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2: Oct-3/4 target genes. Nucleic Acids Res 35: 1773-1786.
2. Chew JL, Loh YH, Zhang W, Chen X, Tam WL, Yeap LS, Li P, Ang YS, Lim B, Robson P, Ng HH. 2005. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 25: 6031-6046.
3. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK. 2009. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27: 289-297.
4. De Brouwer S, De Preter K, Kumps C, Zabrocki P, Porcu M, Westerhout EM, Lakeman A, Vandesompele J, Hoebeeck J, Van Maerken T, De Paepe A, Laureys G, Schulte JH, Schramm A, Van Den Broecke C, Vermeulen J, Van Roy N, Beiske K, Renard M, Noguera R, Delattre O, Janoueix-Lerosey I, Kogner P, Martinsson T, Nakagawara A, Ohira M, Caron H, Eggert A, Cools J, Versteeg R, Speleman F. 2010. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clin Cancer Res 16: 4353-4362.
5. Freier K, Knoepfle K, Flechtenmacher C, Pungs S, Devens F, Toedt G, Hofele C, Joos S, Lichter P, Radlwimmer B. 2010. Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer 49: 9-16.
6. Gure AO, Stockert E, Scanlan MJ, Keresztes RS, Jäger D, Altorki NK, Old LJ, Chen YT. 2000. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci U S A 97: 4188-4203.
7. Holmquist-Mengelbier L, Fredlund E, Löfstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg A, Gradin K, Poellinger L, Påhlman S. 2006. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10: 413-423.
8. Ji J, Zheng PS. 2010. Expression of Sox2 in human cervical carcinogenesis. Hum Pathol 41: 1438-1447.
9. Lu Y, Futtner C, Rock JR, Xu X, Whitworth W, Hogan BL, Onaitis MW. 2010. Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One 5: e11022.
10. Maris JM. 2010. Recent advances in neuroblastoma. N Engl J Med 362: 2202-2211.
11. Melone MA, Giuliano M, Squillaro T, Alessio N, Casale F, Mattioli E, Cipollaro M, Giordano A, Galderisi U. 2009. Genes involved in regulation of stem cell properties: studies on their expression in a small cohort of neuroblastoma patients. Cancer Biol Ther 8: 1300-1306.
12. Noguera R, Fredlund E, Piqueras M, Pietras A, Beckman S, Navarro S, Påhlman S. 2009. HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularization. Clin Cancer Res 15: 7130-7136.
13. Otsubo T, Akiyama Y, Yanagihara K, Yuasa Y. 2008. Sox2 is frequently downregulated in gastric cancers and inhibits cell growth through cellcycle arrest and apoptosis. Br J Cancer 98: 824-831.
14. Pietras A, Gisselsson D, Ora I, Noguera R, Beckman S, Navarro S, Påhlman S. 2008. High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. J Pathol 214: 482-488.
15. Rodriguez-Pinilla SM, Sarrio D, Moreno-Bueno G, Rodriguez-Gil Y, Martinez MA, Hernandez L, Hardisson D, Reis-Filho JS, Palacios J. 2007. Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol 20: 474-481.
16. Sanada Y, Yoshida K, Ohara M, Oeda M, Konishi K, Tsutani Y. 2006. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor Sox2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas 32: 164-170.
17. Sholl LM, Long KB, Hornick JL. 2010. Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas. Appl Immunohistochem Molecul Morphol 18: 55-61.
18. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R, Goodfellow PN. 1990. A gene from the human sexdetermining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346: 240-244.
19. Subramaniam MM, Piqueras M, Navarro S, Noguera R. 2009. Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomas. Hum Pathol 40: 1638-1642.
20. Sutter R, Shakhova O, Bhagat H, Behesti H, Sutter C, Penkar S, Santuccione A, Bernays R, Heppner FL, Schuller U, Grotzer M, Moch H, Schraml P, Marino S. 2010. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene 29: 1845-1856.